1. Systemic adverse effects of ophthalmic medications in the elderly

   Newsletter Article 17 February 2013 Pages: 2 - 2

2. Potential intravascular damage from intramuscular penicillin

   Newsletter Article 17 February 2013 Pages: 2 - 3

3. Amfepramone

   Newsletter Article 17 February 2013 Pages: 3 - 3

4. Amiloride/hydrochlorothiazide

   Newsletter Article 17 February 2013 Pages: 3 - 3

5. Aminoglycosides

   Newsletter Article 17 February 2013 Pages: 3 - 3

6. Anaesthetics see Ritodrine interaction

   Newsletter Article 17 February 2013 Pages: 3 - 3

7. Antidepressants tricyclic

   Newsletter Article 17 February 2013 Pages: 3 - 3

8. Antineoplastics

   Newsletter Article 17 February 2013 Pages: 3 - 3

9. Antituberculars

   Newsletter Article 17 February 2013 Pages: 3 - 3

10. Benzodiazepines

    Newsletter Article 17 February 2013 Pages: 3 - 3

11. Captopril

    Newsletter Article 17 February 2013 Pages: 3 - 4

12. Carboplatin

    Newsletter Article 17 February 2013 Pages: 4 - 4

13. Cefamandole

    Newsletter Article 17 February 2013 Pages: 4 - 4

14. Ceftazidime see Tobramycin/ceftazidime

    Newsletter Article 17 February 2013 Pages: 4 - 4

15. Chloramphenicol interaction

    Newsletter Article 17 February 2013 Pages: 4 - 4

16. Chlorphenamine

    Newsletter Article 17 February 2013 Pages: 4 - 5

17. Cocaine abuse

    Newsletter Article 17 February 2013 Pages: 5 - 5

18. Coumarin

    Newsletter Article 17 February 2013 Pages: 5 - 5

19. Cyclosporin

    Newsletter Article 17 February 2013 Pages: 5 - 5

20. Cyclosporin interaction

    Newsletter Article 17 February 2013 Pages: 6 - 6

21. Dapsone

    Newsletter Article 17 February 2013 Pages: 6 - 6

22. Diamorphine

    Newsletter Article 17 February 2013 Pages: 6 - 6

23. Disulfiram

    Newsletter Article 17 February 2013 Pages: 6 - 6

24. Diuretics

    Newsletter Article 17 February 2013 Pages: 6 - 6

25. Doxorubicin

    Newsletter Article 17 February 2013 Pages: 6 - 7

26. Erythromycin see Cyclosporin interaction

    Newsletter Article 17 February 2013 Pages: 7 - 7

27. Estrogen

    Newsletter Article 17 February 2013 Pages: 7 - 7

28. Etretinate

    Newsletter Article 17 February 2013 Pages: 7 - 7

29. Glucagon

    Newsletter Article 17 February 2013 Pages: 7 - 7

30. Guanethidine

    Newsletter Article 17 February 2013 Pages: 7 - 7

31. Haloperidol

    Newsletter Article 17 February 2013 Pages: 7 - 7

32. Heparin

    Newsletter Article 17 February 2013 Pages: 7 - 7

33. Hydrochlorothiazide see Amiloride

    Newsletter Article 17 February 2013 Pages: 7 - 7

34. Ifosfamide/mesna

    Newsletter Article 17 February 2013 Pages: 7 - 7

35. Isotretinoin

    Newsletter Article 17 February 2013 Pages: 7 - 8

36. Latamoxef

    Newsletter Article 17 February 2013 Pages: 8 - 8

37. Lithium overdose

    Newsletter Article 17 February 2013 Pages: 8 - 8

38. Mesna see Ifosfamide/mesna

    Newsletter Article 17 February 2013 Pages: 8 - 8

39. Methotrexate

    Newsletter Article 17 February 2013 Pages: 8 - 8

40. Methyldopa

    Newsletter Article 17 February 2013 Pages: 8 - 9

41. Mianserin

    Newsletter Article 17 February 2013 Pages: 9 - 9

42. Morphine

    Newsletter Article 17 February 2013 Pages: 9 - 9

43. Mydriatics

    Newsletter Article 17 February 2013 Pages: 9 - 9

44. Nicardipine

    Newsletter Article 17 February 2013 Pages: 9 - 9

45. Nifedipine

    Newsletter Article 17 February 2013 Pages: 9 - 9

46. Nitroglycerin

    Newsletter Article 17 February 2013 Pages: 9 - 9

47. Noscapine see Paracetamol

    Newsletter Article 17 February 2013 Pages: 9 - 9

48. Orphenadrine abuse

    Newsletter Article 17 February 2013 Pages: 9 - 9

49. Paracetamol

    Newsletter Article 17 February 2013 Pages: 9 - 9

50. Paracetamol/noscapine/pheniramine

    Newsletter Article 17 February 2013 Pages: 9 - 9